Crinetics Pharmaceuticals, Inc. (CRNX)

53.12 -0.14 (-0.25%) USD  |  NASDAQ  |  Jan 12, 10:06
More

Crinetics Pharmaceuticals Net Common Equity Issued (Purchased) (Annual)

Net Common Equity Issued (Purchased) (Annual) Chart

View Net Common Equity Issued (Purchased) (Annual) for CRNX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Common Equity Issued (Purchased) (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Common Equity Issued (Purchased) (Annual) Range, Past 5 Years

View Net Common Equity Issued (Purchased) (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Common Equity Issued (Purchased) (Annual) Benchmarks

View Net Common Equity Issued (Purchased) (Annual) Benchmarks
Start Trial
Madrigal Pharmaceuticals, Inc. Upgrade
GT Biopharma, Inc. Upgrade
Axsome Therapeutics, Inc. Upgrade
Sutro Biopharma, Inc. Upgrade
Gossamer Bio, Inc. Upgrade